A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

This study has been completed.

Study NCT00005783 Information provided by National Institutes of Health Clinical Center (CC)

First Received: June 3, 2000 Last Updated: March 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2000
Estimated Primary Completion Date:	No date given